Copyright Reports & Markets. All rights reserved.

Global Intravenous (IV) Iron Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Intravenous (IV) Iron Drugs Market Overview

      • 1.1 Product Overview and Scope of Intravenous (IV) Iron Drugs
      • 1.2 Intravenous (IV) Iron Drugs Segment by Type
        • 1.2.1 Global Intravenous (IV) Iron Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Ferric Carboxymaltose
        • 1.2.3 Iron Sucrose
        • 1.2.4 Iron Dextran
        • 1.2.5 Others
      • 1.3 Intravenous (IV) Iron Drugs Segment by Application
        • 1.3.1 Intravenous (IV) Iron Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Nephrology
        • 1.3.3 Gynecology & Obstetrics
        • 1.3.4 Gastroenterology
        • 1.3.5 Oncology
        • 1.3.6 Cardiology
        • 1.3.7 Others
      • 1.4 Global Intravenous (IV) Iron Drugs Market by Region
        • 1.4.1 Global Intravenous (IV) Iron Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Intravenous (IV) Iron Drugs Market Size
        • 1.5.1 Global Intravenous (IV) Iron Drugs Revenue (2014-2025)
        • 1.5.2 Global Intravenous (IV) Iron Drugs Production (2014-2025)

      2 Global Intravenous (IV) Iron Drugs Market Competition by Manufacturers

      • 2.1 Global Intravenous (IV) Iron Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Intravenous (IV) Iron Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Intravenous (IV) Iron Drugs Production Sites, Area Served, Product Types
      • 2.5 Intravenous (IV) Iron Drugs Market Competitive Situation and Trends
        • 2.5.1 Intravenous (IV) Iron Drugs Market Concentration Rate
        • 2.5.2 Intravenous (IV) Iron Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Intravenous (IV) Iron Drugs Production Market Share by Regions

      • 3.1 Global Intravenous (IV) Iron Drugs Production Market Share by Regions
      • 3.2 Global Intravenous (IV) Iron Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Intravenous (IV) Iron Drugs Production
        • 3.4.1 North America Intravenous (IV) Iron Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Intravenous (IV) Iron Drugs Production
        • 3.5.1 Europe Intravenous (IV) Iron Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Intravenous (IV) Iron Drugs Production (2014-2019)
        • 3.6.1 China Intravenous (IV) Iron Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Intravenous (IV) Iron Drugs Production (2014-2019)
        • 3.7.1 Japan Intravenous (IV) Iron Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Intravenous (IV) Iron Drugs Consumption by Regions

      • 4.1 Global Intravenous (IV) Iron Drugs Consumption by Regions
      • 4.2 North America Intravenous (IV) Iron Drugs Consumption (2014-2019)
      • 4.3 Europe Intravenous (IV) Iron Drugs Consumption (2014-2019)
      • 4.4 China Intravenous (IV) Iron Drugs Consumption (2014-2019)
      • 4.5 Japan Intravenous (IV) Iron Drugs Consumption (2014-2019)

      5 Global Intravenous (IV) Iron Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Intravenous (IV) Iron Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Intravenous (IV) Iron Drugs Price by Type (2014-2019)
      • 5.4 Global Intravenous (IV) Iron Drugs Production Growth by Type (2014-2019)

      6 Global Intravenous (IV) Iron Drugs Market Analysis by Applications

      • 6.1 Global Intravenous (IV) Iron Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Intravenous (IV) Iron Drugs Business

      • 7.1 Sanofi
        • 7.1.1 Sanofi Intravenous (IV) Iron Drugs Production Sites and Area Served
        • 7.1.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
        • 7.1.3 Sanofi Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Allergan
        • 7.2.1 Allergan Intravenous (IV) Iron Drugs Production Sites and Area Served
        • 7.2.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
        • 7.2.3 Allergan Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 AMAG Pharmaceuticals
        • 7.3.1 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production Sites and Area Served
        • 7.3.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
        • 7.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Dalichi Sankyo
        • 7.4.1 Dalichi Sankyo Intravenous (IV) Iron Drugs Production Sites and Area Served
        • 7.4.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
        • 7.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Luitpold Pharmaceuticals
        • 7.5.1 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production Sites and Area Served
        • 7.5.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
        • 7.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Pharmacosmos
        • 7.6.1 Pharmacosmos Intravenous (IV) Iron Drugs Production Sites and Area Served
        • 7.6.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
        • 7.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Takeda Pharmaceutical
        • 7.7.1 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Production Sites and Area Served
        • 7.7.2 Intravenous (IV) Iron Drugs Product Introduction, Application and Specification
        • 7.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served

      8 Intravenous (IV) Iron Drugs Manufacturing Cost Analysis

      • 8.1 Intravenous (IV) Iron Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
      • 8.4 Intravenous (IV) Iron Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Intravenous (IV) Iron Drugs Distributors List
      • 9.3 Intravenous (IV) Iron Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Intravenous (IV) Iron Drugs Market Forecast

      • 11.1 Global Intravenous (IV) Iron Drugs Production, Revenue Forecast
        • 11.1.1 Global Intravenous (IV) Iron Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Intravenous (IV) Iron Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Intravenous (IV) Iron Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Intravenous (IV) Iron Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Intravenous (IV) Iron Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Intravenous (IV) Iron Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Intravenous (IV) Iron Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Intravenous (IV) Iron Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Intravenous (IV) Iron Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Intravenous (IV) Iron Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Intravenous (IV) Iron Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Intravenous (IV) Iron Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Intravenous (IV) Iron Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Intravenous (IV) Iron Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Intravenous (IV) Iron Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Iron infusion is a procedure in which iron is delivered to your body intravenously, meaning into a vein through a needle. This method of delivering medication or supplementation is also known as an intravenous (IV) infusion. Iron infusions are usually prescribed by doctors to treat iron deficiency anemia.
        Iron is one of the most important mineral present inside the human body. It carries oxygen throughout the body via the blood, which is further utilized by cells and tissue to get energy for all vital biological processes. Moreover, deficiency of iron leads to severe health problems, such as anemia and also affects mental or other memory functions in youths. To overcome this problem, oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body. For these cases, IV iron therapy is used to as part of which iron is directly injected inside the body with a needle through a vein.

        The global Intravenous (IV) Iron Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Intravenous (IV) Iron Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intravenous (IV) Iron Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Sanofi
        Allergan
        AMAG Pharmaceuticals
        Dalichi Sankyo
        Luitpold Pharmaceuticals
        Pharmacosmos
        Takeda Pharmaceutical
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Ferric Carboxymaltose
        Iron Sucrose
        Iron Dextran
        Others

        Segment by Application
        Nephrology
        Gynecology & Obstetrics
        Gastroenterology
        Oncology
        Cardiology
        Others

        Buy now